Clinical trial: Renzapride therapy for constipation-predominant irritable bowel syndrome– multicenter, randomized, placebo-controlled, double-blind study in primary healthcare setting

George AM, Meyers NL & Hickling RI. (2008)

Aliment Pharmacol Ther; 27: 830–7